How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

109 results for

Hemicrania Continua

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Hemicrania continua-like headache with leprosy: casual or causal association? (PubMed)

Hemicrania continua-like headache with leprosy: casual or causal association? Hemicrania continua is a strictly unilateral, moderate to severe, continuous, indomethacin-responsive primary headache disorder with ipsilateral autonomic cranial symptoms at the time of exacerbations. We describe a 30-year-old woman with a 4-month history of indomethacin-responsive hemicrania continua-like headache and one-month history of mononeuritis multiplex due to leprosy. Indomethacin was successfully weaned

2008 Headache

82. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. (PubMed)

Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Hemicrania continua (HC) is a primary headache that comprises persistent unilateral pain, is associated with cranial autonomic features, and is responsive to indometacin. Some patients are unable to tolerate this treatment or it is contraindicated; for these patients, the medical options for therapy are restricted. Occipital nerve stimulation (ONS) is an effective

2008 Lancet Neurology

83. Headache

50 years only. There are no other signs or symptoms but intracranial disorders must be excluded. Hemicrania continua : a persistent unilateral headache for three months or more, daily and continuous, of moderate intensity with exacerbations. These feature autonomic symptoms such as eye watering, ptosis and nasal congestion. The condition responds completely to indomethacin. New daily persistent headache : this is a headache that is daily and unremitting virtually from onset. It can resemble TTH

2008 Mentor

84. Adherence to Headache Treatment and Profile of Previous Health Professional Seeking Among Patients with Chronic Headache: A Retrospective Analysis (PubMed)

professionals they had consulted, from none to more than 7.Data from 495 patients were analyzed; 357 were women and 138 were men (ages 6 to 90 years; mean, 41.1 +/- 15.05 years). The headache diagnoses included migraine without aura (43.2%), chronic (transformed) migraine (40%), cluster headache (6.5%), episodic tension-type headache (0.8%), and hemicrania continua (0.4%). The 24.2% of patients who sought care from no more than 1 health professional showed a 59.8% adherence rate; 29% of the total had

Full Text available with Trip Pro

2007 Medscape General Medicine

85. A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache Use of prophylactic headache medication within 28 days prior to week -4 Unremitting headache lasting continuously throughout the 4-week baseline period Known or suspected TMD Diagnosis of fibromyalgia Beck depression inventory score >24 at week-4 Psychiatric problems that may have interfered with study participation Contacts and Locations Go to Information from

2005 Clinical Trials

86. Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

: No Criteria Inclusion Criteria: fulfill 8.2.7 probably medication-overuse headache according to the International Classification of headache disorders, 2th Edition (2004) Exclusion Criteria: No benefit of all available preventative medications, no benefit of abrupt withdrawal lasting more than 3 weeks of acute medication that has been overused, cluster headache, CPH or hemicrania continua, pregnant, use of pain killers of other reasons than headache, other reasons for chronic daily headache than

2005 Clinical Trials

87. A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

at increased risk with exposure to BOTOX Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache Use of prophylactic headache medication within 28 days prior to week -4 Unremitting headache lasting continuously throughout the 4-week baseline period Known or suspected Temporomandibular Disorders (TMD) Diagnosis of fibromyalgia Beck depression inventory score >24 at week-4 Psychiatric problems that may have interfered with study

2005 Clinical Trials

88. The prophylactic treatment of chronic daily headache. (PubMed)

The prophylactic treatment of chronic daily headache. Chronic daily headache (CDH), a heterogeneous group of headache disorders occurring on at least 15 days per month, affects up to 4% to 5% of the general population. CDH disorders include transformed (or chronic) migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua. Patients with CDH have greater disability and lower quality of life than episodic migraine patients and often overuse headache pain

2006 Headache

89. Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs

or less at the frequency range of 200-8000Hz.). Exclusion criteria for migraine subjects: Any other headache diagnosis (e.g. cluster headache, hemicrania continua, post traumatic headache, etc.) except for episodic tension type headache (ETTH) with an average of no more than 10 ETTH headache days per month for the 6 months prior to enrollment (note: average <15 total HA days is specified in inclusion) Use of any headache preventive drug (determined by investigator) in the 90 days prior to screening

2006 Clinical Trials

90. The Sinus, Allergy and Migraine Study (SAMS). (PubMed)

was performed in each patient, and patients were given headache diagnoses based on the current International Headache Society's (IHS) criteria.Of the 100 subjects with self-diagnosed headache, IHS diagnoses mistaken as sinus headache included migraine with or without aura (52%), chronic migraine associated with medication overuse versus probable medication overuse headache (11%), probable migraine (23%), cluster headache (1%), hemicrania continua (1%), headache secondary to rhinosinusitis (3

Full Text available with Trip Pro

2007 Headache

91. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. (PubMed)

) seen between 1998 and 2003 at a headache center. Relevant information was transferred to a standardized form that included operational criteria for the ICHD-2. CDH subtypes were classified according the criteria proposed by S-L into transformed migraine (TM) with (TM+) and without medication overuse (TM-), chronic tension-type headache (CTTH), new daily persistent headache (NDPH), and hemicrania continua (HC).From the 69 patients with TM- according the S-L criteria, most (71%) could be classified

2005 Headache

92. Headaches and pineal cyst: a (more than) coincidental relationship? (PubMed)

diameter 10.1 mm. Two patients had migraine without aura, 1 migraine with aura, 1 chronic migraine, and 1 hemicrania continua. Three patients had strictly unilateral headaches. We hypothesize pineal cysts may be not incidental in headache patients, inducing an abnormal melatonin secretion.

2004 Headache

93. Management of chronic daily headache: challenges in clinical practice. (PubMed)

medication overuse headache, and hemicrania continua (HC). The goal of this review is to enable clinicians to accurately diagnose and effectively manage patients with long-duration CDH. Patients with CDH often require an aggressive and comprehensive treatment approach that includes a combination of acute and preventive medications, as well as nondrug therapies.

2005 Headache

94. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. (PubMed)

fulfilled the criteria of new daily-persistent headache or hemicrania continua. Twenty-four subjects (20%) overused medications. Eighty-two (67%) of all CDH subjects had migraine or probable migraine. In the past semester, most CDH subjects (65%) did not take any sick leave for headaches. Only 6 subjects consulted neurologists in the past year, and only 1 subject took headache prophylactic agents.Chronic daily headache (CDH) was common in a large nonreferred adolescent sample. Based on the International

2006 Neurology

95. The clinical characteristics of headache in patients with pituitary tumours. (PubMed)

The clinical characteristics of headache in patients with pituitary tumours. The clinical characteristics of 84 patients with pituitary tumour who had troublesome headache were investigated. The patients presented with chronic (46%) and episodic (30%) migraine, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT; 5%), cluster headache (4%), hemicrania continua (1%) and primary stabbing headache (27%). It was not possible to classify the headache

Full Text available with Trip Pro

2005 Brain

96. Case series of four different headache types presenting as tooth pain. (PubMed)

Case series of four different headache types presenting as tooth pain. Case reports in the literature discuss various headache disorders that present as pain in the face. The current understanding of neuroanatomy and headache mechanisms suggests that headache pain originates within intracranial structures and is then referred to the face, jaws, and teeth. This case series describes four patients, one each with migraine headache, cluster headache, paroxysmal hemicrania, and hemicrania continua (...) , all of which who presented to dentists with the chief complaint of tooth pain. This is the first report of hemicrania continua presenting as tooth pain. It is important that dentists be cognizant of headache disorders so that they may be able to identify headache pains masquerading as toothache.

2006 Journal of Endodontics

97. Primary chronic daily headache and its subtypes in adolescents and adults. (PubMed)

), chronic tension-type headache (CTTH), new daily persistent headache (NDPH), and hemicrania continua (HC).Among adolescents and adults there were substantial differences in the distribution of CDH subtypes. The relative frequency of TM was lower in adolescents (68.8% vs 87.4%, p < 0.001), while NDPH (21.1% vs 10.8%, p < 0.001) and CTTH (10.1% vs 0.9%, p < 0.0001) were more common. HC (0 vs 0.9%, NS) was equally rare. The lower relative frequency of TM in adolescents was accounted for by TM

2004 Neurology

98. Chronic headache: New advances in treatment strategies. (PubMed)

Chronic headache: New advances in treatment strategies. Chronic daily headache (CDH) affects approximately 4 to 5% of the population and encompasses a number of different diagnoses, including transformed migraine, chronic tension-type headache (TTH), new-onset daily persistent headache, and hemicrania continua. Although the pathophysiology of CDH is still poorly understood, some research has suggested that each of the various subtypes of CDH may have a different pathogenesis. The goals

2002 Neurology

99. Posterior hypothalamic and brainstem activation in hemicrania continua. (PubMed)

Posterior hypothalamic and brainstem activation in hemicrania continua. To determine the brain structures involved in mediating the pain of hemicrania continua using positron emission tomography.Hemicrania continua is a strictly unilateral, continuous headache of moderate intensity, with superimposed exacerbations of severe intensity that are accompanied by trigeminal autonomic features and migrainous symptoms. The syndrome is exquisitely responsive to indomethacin. Its clinical phenotype (...) overlaps with that of the trigeminal autonomic headaches and migraine in which the hypothalamus and the brainstem, respectively, have been postulated to play central pathophysiologic roles. We hypothesized, based on the clinical phenotype, that hemicrania continua may involve activations in the hypothalamus, or dorsal rostral pons, or both.Seven patients with hemicrania continua were studied in two sessions each. In one session, the patients were scanned during baseline pain and when rendered

2004 Headache

100. Hemicrania continua-like headache associated with internal carotid artery dissection may respond to indomethacin. (PubMed)

Hemicrania continua-like headache associated with internal carotid artery dissection may respond to indomethacin. Hemicrania continua (HC) is an idiopathic, chronic disorder characterized by a continuous, strictly unilateral headache associated with ipsilateral cranial autonomic symptoms. The symptoms of HC typically respond dramatically to indomethacin therapy. We describe a patient with traumatic internal carotid artery dissection, who presented with a clinical picture mimicking HC

2007 Headache

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>